1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Neuroblastoma Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Chemotherapy 1.2.3 Immunotherapy 1.2.4 Others 1.3 Market by Application 1.3.1 Global Neuroblastoma Drugs Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Neuroblastoma Drugs Market Perspective (2016-2027) 2.2 Neuroblastoma Drugs Growth Trends by Regions 2.2.1 Neuroblastoma Drugs Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Neuroblastoma Drugs Historic Market Share by Regions (2016-2021) 2.2.3 Neuroblastoma Drugs Forecasted Market Size by Regions (2022-2027) 2.3 Neuroblastoma Drugs Industry Dynamic 2.3.1 Neuroblastoma Drugs Market Trends 2.3.2 Neuroblastoma Drugs Market Drivers 2.3.3 Neuroblastoma Drugs Market Challenges 2.3.4 Neuroblastoma Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Neuroblastoma Drugs Players by Revenue 3.1.1 Global Top Neuroblastoma Drugs Players by Revenue (2016-2021) 3.1.2 Global Neuroblastoma Drugs Revenue Market Share by Players (2016-2021) 3.2 Global Neuroblastoma Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Neuroblastoma Drugs Revenue 3.4 Global Neuroblastoma Drugs Market Concentration Ratio 3.4.1 Global Neuroblastoma Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Neuroblastoma Drugs Revenue in 2020 3.5 Neuroblastoma Drugs Key Players Head office and Area Served 3.6 Key Players Neuroblastoma Drugs Product Solution and Service 3.7 Date of Enter into Neuroblastoma Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Neuroblastoma Drugs Breakdown Data by Type 4.1 Global Neuroblastoma Drugs Historic Market Size by Type (2016-2021) 4.2 Global Neuroblastoma Drugs Forecasted Market Size by Type (2022-2027) 5 Neuroblastoma Drugs Breakdown Data by Application 5.1 Global Neuroblastoma Drugs Historic Market Size by Application (2016-2021) 5.2 Global Neuroblastoma Drugs Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Neuroblastoma Drugs Market Size (2016-2027) 6.2 North America Neuroblastoma Drugs Market Size by Type 6.2.1 North America Neuroblastoma Drugs Market Size by Type (2016-2021) 6.2.2 North America Neuroblastoma Drugs Market Size by Type (2022-2027) 6.2.3 North America Neuroblastoma Drugs Market Size by Type (2016-2027) 6.3 North America Neuroblastoma Drugs Market Size by Application 6.3.1 North America Neuroblastoma Drugs Market Size by Application (2016-2021) 6.3.2 North America Neuroblastoma Drugs Market Size by Application (2022-2027) 6.3.3 North America Neuroblastoma Drugs Market Size by Application (2016-2027) 6.4 North America Neuroblastoma Drugs Market Size by Country 6.4.1 North America Neuroblastoma Drugs Market Size by Country (2016-2021) 6.4.2 North America Neuroblastoma Drugs Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Neuroblastoma Drugs Market Size (2016-2027) 7.2 Europe Neuroblastoma Drugs Market Size by Type 7.2.1 Europe Neuroblastoma Drugs Market Size by Type (2016-2021) 7.2.2 Europe Neuroblastoma Drugs Market Size by Type (2022-2027) 7.2.3 Europe Neuroblastoma Drugs Market Size by Type (2016-2027) 7.3 Europe Neuroblastoma Drugs Market Size by Application 7.3.1 Europe Neuroblastoma Drugs Market Size by Application (2016-2021) 7.3.2 Europe Neuroblastoma Drugs Market Size by Application (2022-2027) 7.3.3 Europe Neuroblastoma Drugs Market Size by Application (2016-2027) 7.4 Europe Neuroblastoma Drugs Market Size by Country 7.4.1 Europe Neuroblastoma Drugs Market Size by Country (2016-2021) 7.4.2 Europe Neuroblastoma Drugs Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Neuroblastoma Drugs Market Size (2016-2027) 8.2 Asia-Pacific Neuroblastoma Drugs Market Size by Type 8.2.1 Asia-Pacific Neuroblastoma Drugs Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Neuroblastoma Drugs Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Neuroblastoma Drugs Market Size by Type (2016-2027) 8.3 Asia-Pacific Neuroblastoma Drugs Market Size by Application 8.3.1 Asia-Pacific Neuroblastoma Drugs Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Neuroblastoma Drugs Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Neuroblastoma Drugs Market Size by Application (2016-2027) 8.4 Asia-Pacific Neuroblastoma Drugs Market Size by Region 8.4.1 Asia-Pacific Neuroblastoma Drugs Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Neuroblastoma Drugs Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Neuroblastoma Drugs Market Size (2016-2027) 9.2 Latin America Neuroblastoma Drugs Market Size by Type 9.2.1 Latin America Neuroblastoma Drugs Market Size by Type (2016-2021) 9.2.2 Latin America Neuroblastoma Drugs Market Size by Type (2022-2027) 9.2.3 Latin America Neuroblastoma Drugs Market Size by Type (2016-2027) 9.3 Latin America Neuroblastoma Drugs Market Size by Application 9.3.1 Latin America Neuroblastoma Drugs Market Size by Application (2016-2021) 9.3.2 Latin America Neuroblastoma Drugs Market Size by Application (2022-2027) 9.3.3 Latin America Neuroblastoma Drugs Market Size by Application (2016-2027) 9.4 Latin America Neuroblastoma Drugs Market Size by Country 9.4.1 Latin America Neuroblastoma Drugs Market Size by Country (2016-2021) 9.4.2 Latin America Neuroblastoma Drugs Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Neuroblastoma Drugs Market Size (2016-2027) 10.2 Middle East & Africa Neuroblastoma Drugs Market Size by Type 10.2.1 Middle East & Africa Neuroblastoma Drugs Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Neuroblastoma Drugs Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Neuroblastoma Drugs Market Size by Type (2016-2027) 10.3 Middle East & Africa Neuroblastoma Drugs Market Size by Application 10.3.1 Middle East & Africa Neuroblastoma Drugs Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Neuroblastoma Drugs Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Neuroblastoma Drugs Market Size by Application (2016-2027) 10.4 Middle East & Africa Neuroblastoma Drugs Market Size by Country 10.4.1 Middle East & Africa Neuroblastoma Drugs Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Neuroblastoma Drugs Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Details 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Neuroblastoma Drugs Introduction 11.1.4 Pfizer Revenue in Neuroblastoma Drugs Business (2016-2021) 11.1.5 Pfizer Recent Development 11.2 Teva Pharmaceutical 11.2.1 Teva Pharmaceutical Company Details 11.2.2 Teva Pharmaceutical Business Overview 11.2.3 Teva Pharmaceutical Neuroblastoma Drugs Introduction 11.2.4 Teva Pharmaceutical Revenue in Neuroblastoma Drugs Business (2016-2021) 11.2.5 Teva Pharmaceutical Recent Development 11.3 Johnson & Johnson 11.3.1 Johnson & Johnson Company Details 11.3.2 Johnson & Johnson Business Overview 11.3.3 Johnson & Johnson Neuroblastoma Drugs Introduction 11.3.4 Johnson & Johnson Revenue in Neuroblastoma Drugs Business (2016-2021) 11.3.5 Johnson & Johnson Recent Development 11.4 Bristol-Myers Squibb 11.4.1 Bristol-Myers Squibb Company Details 11.4.2 Bristol-Myers Squibb Business Overview 11.4.3 Bristol-Myers Squibb Neuroblastoma Drugs Introduction 11.4.4 Bristol-Myers Squibb Revenue in Neuroblastoma Drugs Business (2016-2021) 11.4.5 Bristol-Myers Squibb Recent Development 11.5 United Therapeutics 11.5.1 United Therapeutics Company Details 11.5.2 United Therapeutics Business Overview 11.5.3 United Therapeutics Neuroblastoma Drugs Introduction 11.5.4 United Therapeutics Revenue in Neuroblastoma Drugs Business (2016-2021) 11.5.5 United Therapeutics Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Neuroblastoma Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Chemotherapy Table 3. Key Players of Immunotherapy Table 4. Key Players of Others Table 5. Global Neuroblastoma Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Neuroblastoma Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Neuroblastoma Drugs Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Neuroblastoma Drugs Market Share by Regions (2016-2021) Table 9. Global Neuroblastoma Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Neuroblastoma Drugs Market Share by Regions (2022-2027) Table 11. Neuroblastoma Drugs Market Trends Table 12. Neuroblastoma Drugs Market Drivers Table 13. Neuroblastoma Drugs Market Challenges Table 14. Neuroblastoma Drugs Market Restraints Table 15. Global Neuroblastoma Drugs Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Neuroblastoma Drugs Market Share by Players (2016-2021) Table 17. Global Top Neuroblastoma Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuroblastoma Drugs as of 2020) Table 18. Ranking of Global Top Neuroblastoma Drugs Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Neuroblastoma Drugs Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Neuroblastoma Drugs Product Solution and Service Table 22. Date of Enter into Neuroblastoma Drugs Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Neuroblastoma Drugs Market Size by Type (2016-2021) (US$ Million) Table 25. Global Neuroblastoma Drugs Revenue Market Share by Type (2016-2021) Table 26. Global Neuroblastoma Drugs Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Neuroblastoma Drugs Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Neuroblastoma Drugs Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Neuroblastoma Drugs Revenue Market Share by Application (2016-2021) Table 30. Global Neuroblastoma Drugs Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Neuroblastoma Drugs Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Neuroblastoma Drugs Market Size by Type (2016-2021) (US$ Million) Table 33. North America Neuroblastoma Drugs Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Neuroblastoma Drugs Market Size by Application (2016-2021) (US$ Million) Table 35. North America Neuroblastoma Drugs Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Neuroblastoma Drugs Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Neuroblastoma Drugs Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Neuroblastoma Drugs Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Neuroblastoma Drugs Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Neuroblastoma Drugs Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Neuroblastoma Drugs Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Neuroblastoma Drugs Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Neuroblastoma Drugs Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Neuroblastoma Drugs Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Neuroblastoma Drugs Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Neuroblastoma Drugs Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Neuroblastoma Drugs Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Neuroblastoma Drugs Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Neuroblastoma Drugs Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Neuroblastoma Drugs Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Neuroblastoma Drugs Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Neuroblastoma Drugs Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Neuroblastoma Drugs Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Neuroblastoma Drugs Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Neuroblastoma Drugs Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Neuroblastoma Drugs Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Neuroblastoma Drugs Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Neuroblastoma Drugs Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Neuroblastoma Drugs Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Neuroblastoma Drugs Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Neuroblastoma Drugs Market Size by Country (2022-2027) & (US$ Million) Table 62. Pfizer Company Details Table 63. Pfizer Business Overview Table 64. Pfizer Neuroblastoma Drugs Product Table 65. Pfizer Revenue in Neuroblastoma Drugs Business (2016-2021) & (US$ Million) Table 66. Pfizer Recent Development Table 67. Teva Pharmaceutical Company Details Table 68. Teva Pharmaceutical Business Overview Table 69. Teva Pharmaceutical Neuroblastoma Drugs Product Table 70. Teva Pharmaceutical Revenue in Neuroblastoma Drugs Business (2016-2021) & (US$ Million) Table 71. Teva Pharmaceutical Recent Development Table 72. Johnson & Johnson Company Details Table 73. Johnson & Johnson Business Overview Table 74. Johnson & Johnson Neuroblastoma Drugs Product Table 75. Johnson & Johnson Revenue in Neuroblastoma Drugs Business (2016-2021) & (US$ Million) Table 76. Johnson & Johnson Recent Development Table 77. Bristol-Myers Squibb Company Details Table 78. Bristol-Myers Squibb Business Overview Table 79. Bristol-Myers Squibb Neuroblastoma Drugs Product Table 80. Bristol-Myers Squibb Revenue in Neuroblastoma Drugs Business (2016-2021) & (US$ Million) Table 81. Bristol-Myers Squibb Recent Development Table 82. United Therapeutics Company Details Table 83. United Therapeutics Business Overview Table 84. United Therapeutics Neuroblastoma Drugs Product Table 85. United Therapeutics Revenue in Neuroblastoma Drugs Business (2016-2021) & (US$ Million) Table 86. United Therapeutics Recent Development Table 87. Research Programs/Design for This Report Table 88. Key Data Information from Secondary Sources Table 89. Key Data Information from Primary Sources List of Figures Figure 1. Global Neuroblastoma Drugs Market Share by Type: 2020 VS 2027 Figure 2. Chemotherapy Features Figure 3. Immunotherapy Features Figure 4. Others Features Figure 5. Global Neuroblastoma Drugs Market Share by Application: 2020 VS 2027 Figure 6. Hospitals Case Studies Figure 7. Clinics Case Studies Figure 8. Others Case Studies Figure 9. Neuroblastoma Drugs Report Years Considered Figure 10. Global Neuroblastoma Drugs Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Neuroblastoma Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Neuroblastoma Drugs Market Share by Regions: 2020 VS 2027 Figure 13. Global Neuroblastoma Drugs Market Share by Regions (2022-2027) Figure 14. Global Neuroblastoma Drugs Market Share by Players in 2020 Figure 15. Global Top Neuroblastoma Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuroblastoma Drugs as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Neuroblastoma Drugs Revenue in 2020 Figure 17. Global Neuroblastoma Drugs Revenue Market Share by Type (2016-2021) Figure 18. Global Neuroblastoma Drugs Revenue Market Share by Type (2022-2027) Figure 19. North America Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Neuroblastoma Drugs Market Share by Type (2016-2027) Figure 21. North America Neuroblastoma Drugs Market Share by Application (2016-2027) Figure 22. North America Neuroblastoma Drugs Market Share by Country (2016-2027) Figure 23. United States Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Neuroblastoma Drugs Market Share by Type (2016-2027) Figure 27. Europe Neuroblastoma Drugs Market Share by Application (2016-2027) Figure 28. Europe Neuroblastoma Drugs Market Share by Country (2016-2027) Figure 29. Germany Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Neuroblastoma Drugs Market Share by Type (2016-2027) Figure 37. Asia-Pacific Neuroblastoma Drugs Market Share by Application (2016-2027) Figure 38. Asia-Pacific Neuroblastoma Drugs Market Share by Region (2016-2027) Figure 39. China Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Neuroblastoma Drugs Market Share by Type (2016-2027) Figure 47. Latin America Neuroblastoma Drugs Market Share by Application (2016-2027) Figure 48. Latin America Neuroblastoma Drugs Market Share by Country (2016-2027) Figure 49. Mexico Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Neuroblastoma Drugs Market Share by Type (2016-2027) Figure 53. Middle East & Africa Neuroblastoma Drugs Market Share by Application (2016-2027) Figure 54. Middle East & Africa Neuroblastoma Drugs Market Share by Country (2016-2027) Figure 55. Turkey Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Neuroblastoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Pfizer Revenue Growth Rate in Neuroblastoma Drugs Business (2016-2021) Figure 59. Teva Pharmaceutical Revenue Growth Rate in Neuroblastoma Drugs Business (2016-2021) Figure 60. Johnson & Johnson Revenue Growth Rate in Neuroblastoma Drugs Business (2016-2021) Figure 61. Bristol-Myers Squibb Revenue Growth Rate in Neuroblastoma Drugs Business (2016-2021) Figure 62. United Therapeutics Revenue Growth Rate in Neuroblastoma Drugs Business (2016-2021) Figure 63. Bottom-up and Top-down Approaches for This Report Figure 64. Data Triangulation Figure 65. Key Executives Interviewed

Pfizer Teva Pharmaceutical Johnson & Johnson Bristol-Myers Squibb United Therapeutics